G Pabst

1.0k total citations
48 papers, 596 citations indexed

About

G Pabst is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Analytical Chemistry. According to data from OpenAlex, G Pabst has authored 48 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pediatrics, Perinatology and Child Health, 9 papers in Pharmacology and 9 papers in Analytical Chemistry. Recurrent topics in G Pabst's work include Pharmaceutical studies and practices (13 papers), Analytical Methods in Pharmaceuticals (9 papers) and Diabetes Treatment and Management (5 papers). G Pabst is often cited by papers focused on Pharmaceutical studies and practices (13 papers), Analytical Methods in Pharmaceuticals (9 papers) and Diabetes Treatment and Management (5 papers). G Pabst collaborates with scholars based in Germany, Switzerland and United States. G Pabst's co-authors include H Jaeger, Irmgard Andresen, Johann Bichler, R. Arnold, T Schmeiser, W. Heit, H. Heimpel, Norbert Frickhofen, B. Kubanek and Theodor M. Fliedner and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Critical Care and Clinical Pharmacokinetics.

In The Last Decade

G Pabst

43 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G Pabst Germany	12	99	92	90	77	70	48	596
Yasutomi Kinosada Japan	19	34 0.3×	87 0.9×	107 1.2×	90 1.2×	28 0.4×	63	1.0k
So Young Yoon South Korea	18	73 0.7×	226 2.5×	108 1.2×	163 2.1×	47 0.7×	59	821
M. E. Pickup United Kingdom	15	42 0.4×	62 0.7×	68 0.8×	68 0.9×	53 0.8×	32	695
Masayuki Hashiguchi Japan	16	34 0.3×	96 1.0×	142 1.6×	151 2.0×	87 1.2×	64	936
Myeong Gyu Kim South Korea	15	61 0.6×	70 0.8×	45 0.5×	86 1.1×	56 0.8×	66	649
Eric Snoeck Belgium	18	44 0.4×	114 1.2×	187 2.1×	176 2.3×	73 1.0×	44	1.1k
Jakob Ribbing Sweden	10	57 0.6×	163 1.8×	117 1.3×	126 1.6×	99 1.4×	21	1.0k
Mario Werner United States	19	56 0.6×	87 0.9×	97 1.1×	175 2.3×	106 1.5×	57	896
Poe‐Hirr Hsyu United States	16	111 1.1×	230 2.5×	54 0.6×	222 2.9×	54 0.8×	32	892
Ulrika Wählby Sweden	7	39 0.4×	100 1.1×	71 0.8×	70 0.9×	29 0.4×	8	598

Countries citing papers authored by G Pabst

Since Specialization

Citations

This map shows the geographic impact of G Pabst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Pabst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Pabst more than expected).

Fields of papers citing papers by G Pabst

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Pabst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Pabst. The network helps show where G Pabst may publish in the future.

Co-authorship network of co-authors of G Pabst

This figure shows the co-authorship network connecting the top 25 collaborators of G Pabst. A scholar is included among the top collaborators of G Pabst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Pabst. G Pabst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pabst, G, Klaus Strobel, & James L. Zehnder. (2017). The value of the twinkling artefact for the diagnosis of sialolithiasis of the large salivary glands. The Journal of Laryngology & Otology. 132(2). 162–167. 2 indexed citations

Heger-Mahn, Doris, G Pabst, Angelika Dienel, Sandra Schläfke, & Christine Klipping. (2014). No Interacting Influence of Lavender Oil Preparation Silexan on Oral Contraception Using an Ethinyl Estradiol/Levonorgestrel Combination. Drugs in R&D. 14(4). 265–272. 18 indexed citations

Szeimies, Rolf‐Markus, Peter Radny, Michael Sebastian, et al.. (2010). Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study. British Journal of Dermatology. 163(2). 386–394. 86 indexed citations

Pabst, G, et al.. (2010). Otoplasty Using a Modified Anterior Scoring Technique. Archives of Facial Plastic Surgery. 12(3). 143–8. 15 indexed citations

Pabst, G, et al.. (2010). Otoplasty Using a Modified Anterior Scoring Technique. Archives of Facial Plastic Surgery. 12(3). 143–148. 8 indexed citations

Hol, Myrthe K. S., et al.. (2010). Tympanoplasty in Chronic Otitis Media Patients With an Intact, but Severely Retracted Malleus. Otology & Neurotology. 31(9). 1412–1416. 4 indexed citations

Skrumsager, Birte K., et al.. (2003). Ragaglitazar: The Pharmacokinetics, Pharmacodynamics, and Tolerability of a Novel Dual PPARα and γ Agonist in Healthy Subjects and Patients with Type 2 Diabetes. The Journal of Clinical Pharmacology. 43(11). 1244–1256. 43 indexed citations

Zdravković, Milan, et al.. (2001). Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets. International Journal of Clinical Pharmacology and Therapeutics. 39(1). 41–46. 11 indexed citations

Waitzinger, J., et al.. (1999). Safety and tolerability of naproxen ophthalmic solution in comparison to placebo.. PubMed. 37(3). 133–40. 5 indexed citations

10.

Pabst, G. (1998). [Revalidation of the in vitro specification limits after an in vitro-in vivo correlation].. PubMed. 48(5A). 584–8. 2 indexed citations

11.

Choi, Min Sun, et al.. (1998). Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.. Journal of Antimicrobial Chemotherapy. 42(3). 349–361. 8 indexed citations

12.

Pabst, G, et al.. (1995). [The pharmacokinetics and bioavailability of a new mexiletine preparation in healthy volunteers].. PubMed. 45(3). 254–7. 1 indexed citations

13.

Pabst, G, et al.. (1994). Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers. European Journal of Drug Metabolism and Pharmacokinetics. 19(1). 59–69. 11 indexed citations

14.

Pabst, G. (1994). Deskriptive statistik. Computational Statistics & Data Analysis. 18(4). 474–474. 2 indexed citations

15.

Pabst, G, et al.. (1992). Evaluation of Bioavailability and Pharmacokinetics of Two Isosorbide‐5‐Mononitrate Preparations in Healthy Volunteers. The Journal of Clinical Pharmacology. 32(6). 553–557. 3 indexed citations

16.

Pabst, G, et al.. (1992). Lack of Pharmacokinetic Interactions Between Moxonidine and Digoxin. Clinical Pharmacokinetics. 23(6). 477–481. 4 indexed citations

17.

Pabst, G & H Jaeger. (1990). Review of methods and criteria for the evaluation of bioequivalence studies. European Journal of Clinical Pharmacology. 38(1). 5–10. 57 indexed citations

18.

Pabst, G, et al.. (1990). [Early evening administration of ranitidine in therapy of duodenal ulcer].. PubMed. 28(12). 656–9. 1 indexed citations

19.

Arnold, R., T Schmeiser, W. Heit, et al.. (1986). Hemopoietic reconstitution after bone marrow transplantation.. PubMed. 14(4). 271–7. 70 indexed citations

20.

Pabst, G, et al.. (1985). [Bioavailability of new nifedipine preparations in man. 1. Pharmacokinetics of nifedipine in the form of sustained-release tablets].. PubMed. 35(12). 1840–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact